Skip to main content

Table 1 Clinical and Metabolic characteristics of subjects

From: The atherogenic and metabolic impact of non-HDL cholesterol versus other lipid sub-components among non-diabetic and diabetic Saudis

Variable Non-Diabetics Diabetics P-Value
N 462 271  
Age (years) 45.03 ± 11.52 52.73 ± 11.45 0.000
Systolic BP (mmHg) 120.57 ± 18.23 130.17 ± 19.74 0.000
Diastolic BP (mmHg) 78.15 ± 11.65 82.27 ± 10.71 0.000
BMI (kg/m2) 28.91 ± 6.07 30.15 ± 6.62 0.011
LDL (mmol/L) 3.63 ± 1.31 3.47 ± 1.55 0.17
HDL (mmol/L) 0.91 ± 0.45 0.80 ± 0.32 0.000
Non-HDL (mmol/L) 4.36 ± 1.47 4.67 ± 1.54 0.009
Total Cholesterol (mmol/Ll) 5.26 ± 1.39 5.52 ± 1.74 0.04
Triglycerides (mmol/L) 1.74 ± 1.06 2.63 ± 1.37 0.000
  1. * Data are presented as mean ± SD; p-value significant at < 0.05